Back grey_arrow_rt.gif
 
 
Nature HCV Supplement
 
 
  Download the pdf here

This is supplementary information for the Test & treat this silent killer article by Brian Edlin :Download the pdf here

Supplement
Hepatitis C

Vol. 474 No. 7350_supp S1-S48

nature.gif

· In this Supplement
· Infecting around 120 million people worldwide, hepatitis C virus (HCV) is more common than HIV yet it is a neglected epidemic. Diagnosis is hard, treatment is arduous, and there is no vaccine. However, for the first time in decades, new drugs are about to be launched that could substantially improve treatment and herald a new era of HCV awareness. Free full access Cover Art: Nik Spencer

Outlook

· Hepatitis C
· Herb Brody
· Nature 474, S1 (09 June 2011)
· Introduction: A smouldering public-health crisis
· Lauren Gravitz
· Nature 474, S2-S4 (09 June 2011)
· Therapeutics: New drugs hit the target
· Jana Schl tter
· Nature 474, S5-S7 (09 June 2011)
· Perspective: Miles to go before we sleep
· Charles Rice
· Nature 474, S8 (09 June 2011)
· Pharmacogenomics: Playing the odds
· Amy Maxmen
· Nature 474, S9-S10 (09 June 2011)
· Perspective: Recognizing resistance
· Diana Sylvestre
· Nature 474, S11 (09 June 2011)
· Global health: A uniquely Egyptian epidemic
· Mohammed Yahia
· Nature 474, S12-S13 (09 June 2011)
· Research technique: The murine candidate
· Elie Dolgin
· Nature 474, S14-S15 (09 June 2011)
· Vaccines: A moving target
· Michael Eisenstein
· Nature 474, S16-S17 (09 June 2011)
· Perspective: Test and treat this silent killer
· Brian R. Edlin
· Nature 474, S18-S19 (09 June 2011)
· Diagnostics: A testing journey
· Sarah DeWeerdt
· Nature 474, S20-S21 (09 June 2011)

Collection

· Immune boost for viral hepatitis
· Beno t Callendret &
· Christopher Walker
· Nature Medicine 17, 252-253 (07 March 2011)
· Fighting a defiant virus
· Joshua T Schiffer,
· John Scott &
· Lawrence Corey
· Nature Medicine 17, 253-254 (07 March 2011)
· Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system
· Christopher T Jones,
· Maria Teresa Catanese,
· Lok Man J Law,
· Salman R Khetani,
· Andrew J Syder
· + et al
· Nature Biotechnology 28, 167-171 (31 January 2011)
· Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
· David L. Thomas,
· Chloe L. Thio,
· Maureen P. Martin,
· Ying Qi,
· Dongliang Ge
· + et al
· Nature 461, 798-801 (08 October 2009)
· The dawn of a new era in HCV therapy
· Sandra Ciesek &
· Michael P. Manns
· Nature Reviews Gastroenterology and Hepatology 8, 69-71 (February 2011)
· Enhancing treatment for hepatitis C among drug users
· Jason Grebely &
· Gregory J. Dore
· Nature Reviews Gastroenterology and Hepatology 8, 11-13 (January 2011)
· ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C
· Jacques Fellay,
· Alexander J.Thompson,
· Dongliang Ge,
· Curtis E. Gumbs,
· Thomas J. Urban
· + et al
· Nature 464, 405-408 (18 March 2010)
· Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy
· Magdalena Sarasin-Filipowicz,
· Jacek Krol,
· Ilona Markiewicz,
· Markus H Heim &
· Witold Filipowicz
Nature Medicine 15, 31-33 (January 2009)
 
 
 
 
  icon paper stack View Older Articles   Back to Top   www.natap.org